nodes	percent_of_prediction	percent_of_DWPC	metapath
Propofol—UGT1A9—Irinotecan—colon cancer	0.164	0.228	CbGbCtD
Propofol—UGT1A1—Irinotecan—colon cancer	0.134	0.186	CbGbCtD
Propofol—CYP2A6—Fluorouracil—colon cancer	0.0763	0.106	CbGbCtD
Propofol—CYP2B6—Irinotecan—colon cancer	0.0518	0.072	CbGbCtD
Propofol—ALB—Irinotecan—colon cancer	0.0507	0.0706	CbGbCtD
Propofol—ALB—Fluorouracil—colon cancer	0.0487	0.0677	CbGbCtD
Propofol—CYP2C9—Capecitabine—colon cancer	0.0443	0.0616	CbGbCtD
Propofol—CYP2C8—Fluorouracil—colon cancer	0.0376	0.0523	CbGbCtD
Propofol—CYP1A2—Fluorouracil—colon cancer	0.0291	0.0405	CbGbCtD
Propofol—ALB—Methotrexate—colon cancer	0.0268	0.0374	CbGbCtD
Propofol—CYP2C9—Fluorouracil—colon cancer	0.0262	0.0365	CbGbCtD
Propofol—CYP3A4—Irinotecan—colon cancer	0.0159	0.0221	CbGbCtD
Propofol—CYP3A4—Vincristine—colon cancer	0.0139	0.0193	CbGbCtD
Propofol—UGT1A8—renal system—colon cancer	0.00389	0.0539	CbGeAlD
Propofol—UGT1A6—digestive system—colon cancer	0.00376	0.052	CbGeAlD
Propofol—UGT1A8—digestive system—colon cancer	0.00319	0.0442	CbGeAlD
Propofol—FAAH—renal system—colon cancer	0.00283	0.0391	CbGeAlD
Propofol—UGT1A6—liver—colon cancer	0.0028	0.0387	CbGeAlD
Propofol—UGT1A9—renal system—colon cancer	0.00247	0.0342	CbGeAlD
Propofol—UGT1A8—liver—colon cancer	0.00238	0.0329	CbGeAlD
Propofol—ALB—gall bladder—colon cancer	0.00238	0.0329	CbGeAlD
Propofol—FAAH—vagina—colon cancer	0.00205	0.0283	CbGeAlD
Propofol—UGT1A9—digestive system—colon cancer	0.00203	0.0281	CbGeAlD
Propofol—SCN4A—renal system—colon cancer	0.00184	0.0254	CbGeAlD
Propofol—CYP2C18—digestive system—colon cancer	0.00177	0.0245	CbGeAlD
Propofol—FAAH—liver—colon cancer	0.00173	0.0239	CbGeAlD
Propofol—UGT1A1—renal system—colon cancer	0.00169	0.0234	CbGeAlD
Propofol—CYP2C18—vagina—colon cancer	0.00157	0.0217	CbGeAlD
Propofol—UGT1A9—liver—colon cancer	0.00151	0.0209	CbGeAlD
Propofol—UGT1A1—digestive system—colon cancer	0.00139	0.0192	CbGeAlD
Propofol—FAAH—lymph node—colon cancer	0.00133	0.0183	CbGeAlD
Propofol—CYP2C18—liver—colon cancer	0.00132	0.0183	CbGeAlD
Propofol—Leukocytosis—Fluorouracil—colon cancer	0.00128	0.00783	CcSEcCtD
Propofol—Hiccups—Irinotecan—colon cancer	0.00126	0.00769	CcSEcCtD
Propofol—Salivary hypersecretion—Irinotecan—colon cancer	0.00122	0.00746	CcSEcCtD
Propofol—Neuropathy—Vincristine—colon cancer	0.00121	0.00741	CcSEcCtD
Propofol—Nuchal rigidity—Methotrexate—colon cancer	0.00121	0.00738	CcSEcCtD
Propofol—Thrombosis—Capecitabine—colon cancer	0.00119	0.00727	CcSEcCtD
Propofol—Ileus—Capecitabine—colon cancer	0.00119	0.00727	CcSEcCtD
Propofol—SCN2A—vagina—colon cancer	0.00118	0.0163	CbGeAlD
Propofol—Ventricular fibrillation—Capecitabine—colon cancer	0.0011	0.00672	CcSEcCtD
Propofol—Sepsis—Irinotecan—colon cancer	0.00109	0.00667	CcSEcCtD
Propofol—CYP1B1—smooth muscle tissue—colon cancer	0.00109	0.015	CbGeAlD
Propofol—Coagulopathy—Capecitabine—colon cancer	0.00108	0.00661	CcSEcCtD
Propofol—Tingling sensation—Capecitabine—colon cancer	0.00105	0.0064	CcSEcCtD
Propofol—Myocardial ischaemia—Capecitabine—colon cancer	0.00105	0.0064	CcSEcCtD
Propofol—Sepsis—Fluorouracil—colon cancer	0.00105	0.00639	CcSEcCtD
Propofol—CYP1B1—renal system—colon cancer	0.00105	0.0145	CbGeAlD
Propofol—Euphoric mood—Fluorouracil—colon cancer	0.00104	0.00632	CcSEcCtD
Propofol—UGT1A1—liver—colon cancer	0.00104	0.0143	CbGeAlD
Propofol—CYP2A6—vagina—colon cancer	0.00103	0.0143	CbGeAlD
Propofol—Injection site pain—Capecitabine—colon cancer	0.00103	0.0063	CcSEcCtD
Propofol—Extrasystoles—Capecitabine—colon cancer	0.001	0.00611	CcSEcCtD
Propofol—Hypoxia—Methotrexate—colon cancer	0.000988	0.00603	CcSEcCtD
Propofol—Anaphylactoid reaction—Irinotecan—colon cancer	0.000945	0.00576	CcSEcCtD
Propofol—Musculoskeletal stiffness—Capecitabine—colon cancer	0.00094	0.00573	CcSEcCtD
Propofol—Pain in extremity—Vincristine—colon cancer	0.000939	0.00573	CcSEcCtD
Propofol—Ventricular extrasystoles—Capecitabine—colon cancer	0.000934	0.00569	CcSEcCtD
Propofol—GABRA2—vagina—colon cancer	0.000914	0.0126	CbGeAlD
Propofol—Cardiac failure—Fluorouracil—colon cancer	0.000898	0.00547	CcSEcCtD
Propofol—Urinary retention—Vincristine—colon cancer	0.000893	0.00545	CcSEcCtD
Propofol—Cardiac arrest—Vincristine—colon cancer	0.000893	0.00545	CcSEcCtD
Propofol—Dehydration—Vincristine—colon cancer	0.000874	0.00533	CcSEcCtD
Propofol—CYP2A6—liver—colon cancer	0.000873	0.0121	CbGeAlD
Propofol—Cardiac arrest—Irinotecan—colon cancer	0.00087	0.0053	CcSEcCtD
Propofol—CYP1B1—lymphoid tissue—colon cancer	0.000869	0.012	CbGeAlD
Propofol—CYP1B1—digestive system—colon cancer	0.000859	0.0119	CbGeAlD
Propofol—Blood creatinine increased—Irinotecan—colon cancer	0.000857	0.00523	CcSEcCtD
Propofol—Dehydration—Irinotecan—colon cancer	0.000851	0.00519	CcSEcCtD
Propofol—Hiccups—Capecitabine—colon cancer	0.000844	0.00514	CcSEcCtD
Propofol—Cardiac arrest—Fluorouracil—colon cancer	0.000833	0.00508	CcSEcCtD
Propofol—Cramp muscle—Irinotecan—colon cancer	0.000824	0.00502	CcSEcCtD
Propofol—CYP2C8—renal system—colon cancer	0.000802	0.0111	CbGeAlD
Propofol—CYP1A1—epithelium—colon cancer	0.000798	0.011	CbGeAlD
Propofol—Neuropathy—Capecitabine—colon cancer	0.000792	0.00483	CcSEcCtD
Propofol—Pancreatitis—Irinotecan—colon cancer	0.000775	0.00473	CcSEcCtD
Propofol—Sweating increased—Irinotecan—colon cancer	0.00077	0.0047	CcSEcCtD
Propofol—CYP2C19—digestive system—colon cancer	0.000753	0.0104	CbGeAlD
Propofol—CYP1A2—renal system—colon cancer	0.00075	0.0104	CbGeAlD
Propofol—Apnoea—Methotrexate—colon cancer	0.000741	0.00452	CcSEcCtD
Propofol—CYP1A1—renal system—colon cancer	0.00074	0.0102	CbGeAlD
Propofol—Abnormal vision—Capecitabine—colon cancer	0.000736	0.00449	CcSEcCtD
Propofol—Mental disability—Capecitabine—colon cancer	0.000732	0.00446	CcSEcCtD
Propofol—Sepsis—Capecitabine—colon cancer	0.000732	0.00446	CcSEcCtD
Propofol—Depression—Vincristine—colon cancer	0.000722	0.0044	CcSEcCtD
Propofol—Extravasation—Methotrexate—colon cancer	0.00072	0.00439	CcSEcCtD
Propofol—CYP2B6—renal system—colon cancer	0.000719	0.00995	CbGeAlD
Propofol—Ear pain—Capecitabine—colon cancer	0.000718	0.00438	CcSEcCtD
Propofol—Acute coronary syndrome—Vincristine—colon cancer	0.000714	0.00435	CcSEcCtD
Propofol—Phlebitis—Capecitabine—colon cancer	0.000711	0.00433	CcSEcCtD
Propofol—Myocardial infarction—Vincristine—colon cancer	0.00071	0.00433	CcSEcCtD
Propofol—Neuropathy peripheral—Vincristine—colon cancer	0.00071	0.00433	CcSEcCtD
Propofol—Musculoskeletal stiffness—Methotrexate—colon cancer	0.0007	0.00427	CcSEcCtD
Propofol—ALB—liver—colon cancer	0.000697	0.00964	CbGeAlD
Propofol—Acute coronary syndrome—Irinotecan—colon cancer	0.000695	0.00424	CcSEcCtD
Propofol—Renal failure—Irinotecan—colon cancer	0.000693	0.00423	CcSEcCtD
Propofol—Myocardial infarction—Irinotecan—colon cancer	0.000691	0.00421	CcSEcCtD
Propofol—Oliguria—Methotrexate—colon cancer	0.000681	0.00415	CcSEcCtD
Propofol—Eye pain—Capecitabine—colon cancer	0.000678	0.00414	CcSEcCtD
Propofol—CYP2E1—renal system—colon cancer	0.000675	0.00934	CbGeAlD
Propofol—Acute coronary syndrome—Fluorouracil—colon cancer	0.000666	0.00406	CcSEcCtD
Propofol—CYP2C19—vagina—colon cancer	0.000665	0.0092	CbGeAlD
Propofol—Neuropathy peripheral—Fluorouracil—colon cancer	0.000662	0.00404	CcSEcCtD
Propofol—Myocardial infarction—Fluorouracil—colon cancer	0.000662	0.00404	CcSEcCtD
Propofol—GABRB3—liver—colon cancer	0.000648	0.00897	CbGeAlD
Propofol—Hallucination—Vincristine—colon cancer	0.000647	0.00394	CcSEcCtD
Propofol—Atrial fibrillation—Capecitabine—colon cancer	0.000646	0.00394	CcSEcCtD
Propofol—Bradycardia—Irinotecan—colon cancer	0.000644	0.00393	CcSEcCtD
Propofol—CYP1B1—liver—colon cancer	0.00064	0.00885	CbGeAlD
Propofol—Respiratory failure—Methotrexate—colon cancer	0.000639	0.0039	CcSEcCtD
Propofol—Haemoglobin—Irinotecan—colon cancer	0.000636	0.00388	CcSEcCtD
Propofol—Haemorrhage—Irinotecan—colon cancer	0.000633	0.00386	CcSEcCtD
Propofol—Cardiac failure—Capecitabine—colon cancer	0.000627	0.00383	CcSEcCtD
Propofol—CYP1A2—digestive system—colon cancer	0.000615	0.00851	CbGeAlD
Propofol—Pain in extremity—Capecitabine—colon cancer	0.000612	0.00373	CcSEcCtD
Propofol—Diplopia—Capecitabine—colon cancer	0.000612	0.00373	CcSEcCtD
Propofol—Visual impairment—Irinotecan—colon cancer	0.00061	0.00372	CcSEcCtD
Propofol—Haemoglobin—Fluorouracil—colon cancer	0.000609	0.00372	CcSEcCtD
Propofol—CYP1A1—digestive system—colon cancer	0.000607	0.0084	CbGeAlD
Propofol—Haemorrhage—Fluorouracil—colon cancer	0.000606	0.0037	CcSEcCtD
Propofol—Pharyngitis—Fluorouracil—colon cancer	0.000602	0.00367	CcSEcCtD
Propofol—CYP2B6—lymphoid tissue—colon cancer	0.000597	0.00826	CbGeAlD
Propofol—GABRA2—lymph node—colon cancer	0.000591	0.00818	CbGeAlD
Propofol—CYP2B6—digestive system—colon cancer	0.00059	0.00816	CbGeAlD
Propofol—Flushing—Irinotecan—colon cancer	0.000587	0.00358	CcSEcCtD
Propofol—CYP2C9—digestive system—colon cancer	0.000584	0.00808	CbGeAlD
Propofol—Urinary retention—Capecitabine—colon cancer	0.000582	0.00355	CcSEcCtD
Propofol—Cardiac arrest—Capecitabine—colon cancer	0.000582	0.00355	CcSEcCtD
Propofol—CYP2C8—vagina—colon cancer	0.000581	0.00803	CbGeAlD
Propofol—Mood swings—Capecitabine—colon cancer	0.00058	0.00354	CcSEcCtD
Propofol—Blood creatinine increased—Capecitabine—colon cancer	0.000574	0.0035	CcSEcCtD
Propofol—Dehydration—Capecitabine—colon cancer	0.000569	0.00347	CcSEcCtD
Propofol—Chills—Irinotecan—colon cancer	0.000568	0.00346	CcSEcCtD
Propofol—Arrhythmia—Irinotecan—colon cancer	0.000565	0.00345	CcSEcCtD
Propofol—CYP2C19—liver—colon cancer	0.000561	0.00777	CbGeAlD
Propofol—CYP2E1—lymphoid tissue—colon cancer	0.00056	0.00775	CbGeAlD
Propofol—Pulmonary oedema—Methotrexate—colon cancer	0.000559	0.00341	CcSEcCtD
Propofol—CYP2E1—digestive system—colon cancer	0.000554	0.00766	CbGeAlD
Propofol—Sepsis—Methotrexate—colon cancer	0.000545	0.00332	CcSEcCtD
Propofol—CYP3A4—renal system—colon cancer	0.000543	0.00751	CbGeAlD
Propofol—Arrhythmia—Fluorouracil—colon cancer	0.000541	0.0033	CcSEcCtD
Propofol—CYP1A1—vagina—colon cancer	0.000536	0.00742	CbGeAlD
Propofol—ALB—lymph node—colon cancer	0.000535	0.00739	CbGeAlD
Propofol—CYP2D6—renal system—colon cancer	0.000534	0.00739	CbGeAlD
Propofol—Muscle spasms—Irinotecan—colon cancer	0.00053	0.00323	CcSEcCtD
Propofol—Erythema—Fluorouracil—colon cancer	0.000528	0.00322	CcSEcCtD
Propofol—CYP2B6—vagina—colon cancer	0.000521	0.00721	CbGeAlD
Propofol—Bronchospasm—Capecitabine—colon cancer	0.000521	0.00317	CcSEcCtD
Propofol—Agitation—Vincristine—colon cancer	0.00052	0.00317	CcSEcCtD
Propofol—Sweating increased—Capecitabine—colon cancer	0.000515	0.00314	CcSEcCtD
Propofol—Syncope—Irinotecan—colon cancer	0.000494	0.00301	CcSEcCtD
Propofol—CYP1B1—lymph node—colon cancer	0.00049	0.00679	CbGeAlD
Propofol—Convulsion—Vincristine—colon cancer	0.00049	0.00299	CcSEcCtD
Propofol—CYP2C8—liver—colon cancer	0.00049	0.00678	CbGeAlD
Propofol—Hypertension—Vincristine—colon cancer	0.000488	0.00298	CcSEcCtD
Propofol—Loss of consciousness—Irinotecan—colon cancer	0.000484	0.00295	CcSEcCtD
Propofol—Myalgia—Vincristine—colon cancer	0.000482	0.00294	CcSEcCtD
Propofol—Cough—Irinotecan—colon cancer	0.000481	0.00293	CcSEcCtD
Propofol—Hyperglycaemia—Capecitabine—colon cancer	0.000477	0.00291	CcSEcCtD
Propofol—Hypertension—Irinotecan—colon cancer	0.000476	0.0029	CcSEcCtD
Propofol—Anaphylactoid reaction—Methotrexate—colon cancer	0.000471	0.00287	CcSEcCtD
Propofol—Depression—Capecitabine—colon cancer	0.00047	0.00287	CcSEcCtD
Propofol—Acute coronary syndrome—Capecitabine—colon cancer	0.000465	0.00284	CcSEcCtD
Propofol—Renal failure—Capecitabine—colon cancer	0.000464	0.00283	CcSEcCtD
Propofol—Neuropathy peripheral—Capecitabine—colon cancer	0.000463	0.00282	CcSEcCtD
Propofol—Myocardial infarction—Capecitabine—colon cancer	0.000463	0.00282	CcSEcCtD
Propofol—Oedema—Vincristine—colon cancer	0.000462	0.00282	CcSEcCtD
Propofol—Anaphylactic shock—Vincristine—colon cancer	0.000462	0.00282	CcSEcCtD
Propofol—CYP1A2—liver—colon cancer	0.000458	0.00634	CbGeAlD
Propofol—Convulsion—Fluorouracil—colon cancer	0.000457	0.00279	CcSEcCtD
Propofol—Confusional state—Irinotecan—colon cancer	0.000453	0.00276	CcSEcCtD
Propofol—CYP1A1—liver—colon cancer	0.000452	0.00626	CbGeAlD
Propofol—Oedema—Irinotecan—colon cancer	0.00045	0.00274	CcSEcCtD
Propofol—Anaphylactic shock—Irinotecan—colon cancer	0.00045	0.00274	CcSEcCtD
Propofol—Myalgia—Fluorouracil—colon cancer	0.000449	0.00274	CcSEcCtD
Propofol—Chest pain—Fluorouracil—colon cancer	0.000449	0.00274	CcSEcCtD
Propofol—Hyperhidrosis—Vincristine—colon cancer	0.000446	0.00272	CcSEcCtD
Propofol—CYP3A4—digestive system—colon cancer	0.000445	0.00616	CbGeAlD
Propofol—Shock—Irinotecan—colon cancer	0.000442	0.0027	CcSEcCtD
Propofol—CYP2B6—liver—colon cancer	0.000439	0.00608	CbGeAlD
Propofol—CYP2D6—digestive system—colon cancer	0.000438	0.00606	CbGeAlD
Propofol—CYP2C9—liver—colon cancer	0.000435	0.00602	CbGeAlD
Propofol—Hyperhidrosis—Irinotecan—colon cancer	0.000435	0.00265	CcSEcCtD
Propofol—Confusional state—Fluorouracil—colon cancer	0.000434	0.00265	CcSEcCtD
Propofol—Mood swings—Methotrexate—colon cancer	0.000432	0.00263	CcSEcCtD
Propofol—Hypotension—Vincristine—colon cancer	0.000431	0.00263	CcSEcCtD
Propofol—Bradycardia—Capecitabine—colon cancer	0.000431	0.00263	CcSEcCtD
Propofol—Anaphylactic shock—Fluorouracil—colon cancer	0.000431	0.00263	CcSEcCtD
Propofol—Oedema—Fluorouracil—colon cancer	0.000431	0.00263	CcSEcCtD
Propofol—Haemoglobin—Capecitabine—colon cancer	0.000426	0.0026	CcSEcCtD
Propofol—Haemorrhage—Capecitabine—colon cancer	0.000424	0.00258	CcSEcCtD
Propofol—Musculoskeletal discomfort—Vincristine—colon cancer	0.000421	0.00257	CcSEcCtD
Propofol—Pharyngitis—Capecitabine—colon cancer	0.00042	0.00256	CcSEcCtD
Propofol—Tachycardia—Fluorouracil—colon cancer	0.00042	0.00256	CcSEcCtD
Propofol—Hypotension—Irinotecan—colon cancer	0.00042	0.00256	CcSEcCtD
Propofol—Insomnia—Vincristine—colon cancer	0.000418	0.00255	CcSEcCtD
Propofol—Paraesthesia—Vincristine—colon cancer	0.000415	0.00253	CcSEcCtD
Propofol—CYP2E1—liver—colon cancer	0.000412	0.00571	CbGeAlD
Propofol—Visual impairment—Capecitabine—colon cancer	0.000408	0.00249	CcSEcCtD
Propofol—Insomnia—Irinotecan—colon cancer	0.000407	0.00248	CcSEcCtD
Propofol—Paraesthesia—Irinotecan—colon cancer	0.000404	0.00246	CcSEcCtD
Propofol—Hypotension—Fluorouracil—colon cancer	0.000402	0.00245	CcSEcCtD
Propofol—Dyspnoea—Irinotecan—colon cancer	0.000401	0.00244	CcSEcCtD
Propofol—Somnolence—Irinotecan—colon cancer	0.0004	0.00244	CcSEcCtD
Propofol—Fatigue—Vincristine—colon cancer	0.000398	0.00243	CcSEcCtD
Propofol—Tinnitus—Capecitabine—colon cancer	0.000395	0.00241	CcSEcCtD
Propofol—Pain—Vincristine—colon cancer	0.000395	0.00241	CcSEcCtD
Propofol—Flushing—Capecitabine—colon cancer	0.000393	0.0024	CcSEcCtD
Propofol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000392	0.00239	CcSEcCtD
Propofol—Insomnia—Fluorouracil—colon cancer	0.000389	0.00238	CcSEcCtD
Propofol—Fatigue—Irinotecan—colon cancer	0.000388	0.00236	CcSEcCtD
Propofol—Paraesthesia—Fluorouracil—colon cancer	0.000387	0.00236	CcSEcCtD
Propofol—Pancreatitis—Methotrexate—colon cancer	0.000386	0.00236	CcSEcCtD
Propofol—Pain—Irinotecan—colon cancer	0.000384	0.00234	CcSEcCtD
Propofol—Dyspnoea—Fluorouracil—colon cancer	0.000384	0.00234	CcSEcCtD
Propofol—Somnolence—Fluorouracil—colon cancer	0.000383	0.00233	CcSEcCtD
Propofol—Chills—Capecitabine—colon cancer	0.00038	0.00232	CcSEcCtD
Propofol—Arrhythmia—Capecitabine—colon cancer	0.000378	0.00231	CcSEcCtD
Propofol—Feeling abnormal—Irinotecan—colon cancer	0.000371	0.00226	CcSEcCtD
Propofol—Erythema—Capecitabine—colon cancer	0.000369	0.00225	CcSEcCtD
Propofol—Pain—Fluorouracil—colon cancer	0.000368	0.00225	CcSEcCtD
Propofol—Abdominal pain—Vincristine—colon cancer	0.000365	0.00223	CcSEcCtD
Propofol—Body temperature increased—Vincristine—colon cancer	0.000365	0.00223	CcSEcCtD
Propofol—Dysgeusia—Capecitabine—colon cancer	0.000361	0.0022	CcSEcCtD
Propofol—Abdominal pain—Irinotecan—colon cancer	0.000355	0.00217	CcSEcCtD
Propofol—Body temperature increased—Irinotecan—colon cancer	0.000355	0.00217	CcSEcCtD
Propofol—Feeling abnormal—Fluorouracil—colon cancer	0.000355	0.00216	CcSEcCtD
Propofol—Muscle spasms—Capecitabine—colon cancer	0.000355	0.00216	CcSEcCtD
Propofol—Depression—Methotrexate—colon cancer	0.00035	0.00214	CcSEcCtD
Propofol—CYP1A1—lymph node—colon cancer	0.000347	0.0048	CbGeAlD
Propofol—Tremor—Capecitabine—colon cancer	0.000345	0.00211	CcSEcCtD
Propofol—Renal failure—Methotrexate—colon cancer	0.000345	0.00211	CcSEcCtD
Propofol—Urticaria—Fluorouracil—colon cancer	0.000342	0.00209	CcSEcCtD
Propofol—Body temperature increased—Fluorouracil—colon cancer	0.00034	0.00208	CcSEcCtD
Propofol—CYP3A4—liver—colon cancer	0.000332	0.00459	CbGeAlD
Propofol—Asthenia—Vincristine—colon cancer	0.000331	0.00202	CcSEcCtD
Propofol—Syncope—Capecitabine—colon cancer	0.000331	0.00202	CcSEcCtD
Propofol—CYP2D6—liver—colon cancer	0.000327	0.00452	CbGeAlD
Propofol—Loss of consciousness—Capecitabine—colon cancer	0.000324	0.00198	CcSEcCtD
Propofol—Asthenia—Irinotecan—colon cancer	0.000323	0.00197	CcSEcCtD
Propofol—Cough—Capecitabine—colon cancer	0.000322	0.00196	CcSEcCtD
Propofol—Hypertension—Capecitabine—colon cancer	0.000318	0.00194	CcSEcCtD
Propofol—Haemoglobin—Methotrexate—colon cancer	0.000317	0.00193	CcSEcCtD
Propofol—Diarrhoea—Vincristine—colon cancer	0.000316	0.00193	CcSEcCtD
Propofol—Haemorrhage—Methotrexate—colon cancer	0.000315	0.00192	CcSEcCtD
Propofol—Chest pain—Capecitabine—colon cancer	0.000314	0.00191	CcSEcCtD
Propofol—Myalgia—Capecitabine—colon cancer	0.000314	0.00191	CcSEcCtD
Propofol—Pharyngitis—Methotrexate—colon cancer	0.000313	0.00191	CcSEcCtD
Propofol—Anxiety—Capecitabine—colon cancer	0.000313	0.00191	CcSEcCtD
Propofol—Diarrhoea—Irinotecan—colon cancer	0.000308	0.00188	CcSEcCtD
Propofol—Dry mouth—Capecitabine—colon cancer	0.000307	0.00187	CcSEcCtD
Propofol—Dizziness—Vincristine—colon cancer	0.000305	0.00186	CcSEcCtD
Propofol—Pruritus—Fluorouracil—colon cancer	0.000305	0.00186	CcSEcCtD
Propofol—Visual impairment—Methotrexate—colon cancer	0.000304	0.00185	CcSEcCtD
Propofol—Confusional state—Capecitabine—colon cancer	0.000303	0.00185	CcSEcCtD
Propofol—Oedema—Capecitabine—colon cancer	0.000301	0.00184	CcSEcCtD
Propofol—Dizziness—Irinotecan—colon cancer	0.000297	0.00181	CcSEcCtD
Propofol—Shock—Capecitabine—colon cancer	0.000296	0.00181	CcSEcCtD
Propofol—Diarrhoea—Fluorouracil—colon cancer	0.000295	0.0018	CcSEcCtD
Propofol—Tinnitus—Methotrexate—colon cancer	0.000294	0.00179	CcSEcCtD
Propofol—Tachycardia—Capecitabine—colon cancer	0.000294	0.00179	CcSEcCtD
Propofol—Vomiting—Vincristine—colon cancer	0.000294	0.00179	CcSEcCtD
Propofol—Rash—Vincristine—colon cancer	0.000291	0.00178	CcSEcCtD
Propofol—Hyperhidrosis—Capecitabine—colon cancer	0.000291	0.00177	CcSEcCtD
Propofol—Dermatitis—Vincristine—colon cancer	0.000291	0.00177	CcSEcCtD
Propofol—Headache—Vincristine—colon cancer	0.000289	0.00176	CcSEcCtD
Propofol—Vomiting—Irinotecan—colon cancer	0.000286	0.00174	CcSEcCtD
Propofol—Dizziness—Fluorouracil—colon cancer	0.000285	0.00174	CcSEcCtD
Propofol—Rash—Irinotecan—colon cancer	0.000283	0.00173	CcSEcCtD
Propofol—Dermatitis—Irinotecan—colon cancer	0.000283	0.00173	CcSEcCtD
Propofol—Chills—Methotrexate—colon cancer	0.000283	0.00173	CcSEcCtD
Propofol—Headache—Irinotecan—colon cancer	0.000282	0.00172	CcSEcCtD
Propofol—Hypotension—Capecitabine—colon cancer	0.000281	0.00171	CcSEcCtD
Propofol—Erythema—Methotrexate—colon cancer	0.000274	0.00167	CcSEcCtD
Propofol—Nausea—Vincristine—colon cancer	0.000274	0.00167	CcSEcCtD
Propofol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000274	0.00167	CcSEcCtD
Propofol—Vomiting—Fluorouracil—colon cancer	0.000274	0.00167	CcSEcCtD
Propofol—Insomnia—Capecitabine—colon cancer	0.000272	0.00166	CcSEcCtD
Propofol—Rash—Fluorouracil—colon cancer	0.000272	0.00166	CcSEcCtD
Propofol—Dermatitis—Fluorouracil—colon cancer	0.000271	0.00165	CcSEcCtD
Propofol—Paraesthesia—Capecitabine—colon cancer	0.00027	0.00165	CcSEcCtD
Propofol—Headache—Fluorouracil—colon cancer	0.00027	0.00165	CcSEcCtD
Propofol—Dysgeusia—Methotrexate—colon cancer	0.000269	0.00164	CcSEcCtD
Propofol—Dyspnoea—Capecitabine—colon cancer	0.000268	0.00164	CcSEcCtD
Propofol—Nausea—Irinotecan—colon cancer	0.000267	0.00163	CcSEcCtD
Propofol—Fatigue—Capecitabine—colon cancer	0.000259	0.00158	CcSEcCtD
Propofol—Pain—Capecitabine—colon cancer	0.000257	0.00157	CcSEcCtD
Propofol—Nausea—Fluorouracil—colon cancer	0.000256	0.00156	CcSEcCtD
Propofol—Feeling abnormal—Capecitabine—colon cancer	0.000248	0.00151	CcSEcCtD
Propofol—Cough—Methotrexate—colon cancer	0.00024	0.00146	CcSEcCtD
Propofol—Urticaria—Capecitabine—colon cancer	0.000239	0.00146	CcSEcCtD
Propofol—Body temperature increased—Capecitabine—colon cancer	0.000238	0.00145	CcSEcCtD
Propofol—Abdominal pain—Capecitabine—colon cancer	0.000238	0.00145	CcSEcCtD
Propofol—Convulsion—Methotrexate—colon cancer	0.000238	0.00145	CcSEcCtD
Propofol—Chest pain—Methotrexate—colon cancer	0.000234	0.00143	CcSEcCtD
Propofol—Myalgia—Methotrexate—colon cancer	0.000234	0.00143	CcSEcCtD
Propofol—Confusional state—Methotrexate—colon cancer	0.000226	0.00138	CcSEcCtD
Propofol—Anaphylactic shock—Methotrexate—colon cancer	0.000224	0.00137	CcSEcCtD
Propofol—Hyperhidrosis—Methotrexate—colon cancer	0.000217	0.00132	CcSEcCtD
Propofol—Asthenia—Capecitabine—colon cancer	0.000216	0.00132	CcSEcCtD
Propofol—Pruritus—Capecitabine—colon cancer	0.000213	0.0013	CcSEcCtD
Propofol—Hypotension—Methotrexate—colon cancer	0.000209	0.00128	CcSEcCtD
Propofol—Diarrhoea—Capecitabine—colon cancer	0.000206	0.00126	CcSEcCtD
Propofol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000204	0.00124	CcSEcCtD
Propofol—Insomnia—Methotrexate—colon cancer	0.000203	0.00124	CcSEcCtD
Propofol—Paraesthesia—Methotrexate—colon cancer	0.000201	0.00123	CcSEcCtD
Propofol—Dyspnoea—Methotrexate—colon cancer	0.0002	0.00122	CcSEcCtD
Propofol—Somnolence—Methotrexate—colon cancer	0.000199	0.00121	CcSEcCtD
Propofol—Dizziness—Capecitabine—colon cancer	0.000199	0.00121	CcSEcCtD
Propofol—Fatigue—Methotrexate—colon cancer	0.000193	0.00118	CcSEcCtD
Propofol—Pain—Methotrexate—colon cancer	0.000192	0.00117	CcSEcCtD
Propofol—Vomiting—Capecitabine—colon cancer	0.000191	0.00117	CcSEcCtD
Propofol—Rash—Capecitabine—colon cancer	0.00019	0.00116	CcSEcCtD
Propofol—Dermatitis—Capecitabine—colon cancer	0.00019	0.00116	CcSEcCtD
Propofol—Headache—Capecitabine—colon cancer	0.000189	0.00115	CcSEcCtD
Propofol—Feeling abnormal—Methotrexate—colon cancer	0.000185	0.00113	CcSEcCtD
Propofol—Nausea—Capecitabine—colon cancer	0.000179	0.00109	CcSEcCtD
Propofol—Urticaria—Methotrexate—colon cancer	0.000178	0.00109	CcSEcCtD
Propofol—Abdominal pain—Methotrexate—colon cancer	0.000177	0.00108	CcSEcCtD
Propofol—Body temperature increased—Methotrexate—colon cancer	0.000177	0.00108	CcSEcCtD
Propofol—Asthenia—Methotrexate—colon cancer	0.000161	0.00098	CcSEcCtD
Propofol—Pruritus—Methotrexate—colon cancer	0.000158	0.000967	CcSEcCtD
Propofol—Diarrhoea—Methotrexate—colon cancer	0.000153	0.000935	CcSEcCtD
Propofol—Dizziness—Methotrexate—colon cancer	0.000148	0.000903	CcSEcCtD
Propofol—Vomiting—Methotrexate—colon cancer	0.000142	0.000869	CcSEcCtD
Propofol—Rash—Methotrexate—colon cancer	0.000141	0.000861	CcSEcCtD
Propofol—Dermatitis—Methotrexate—colon cancer	0.000141	0.000861	CcSEcCtD
Propofol—Headache—Methotrexate—colon cancer	0.00014	0.000856	CcSEcCtD
Propofol—Nausea—Methotrexate—colon cancer	0.000133	0.000811	CcSEcCtD
Propofol—SCN2A—Developmental Biology—CTNNB1—colon cancer	4.73e-05	0.00105	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—CTNNB1—colon cancer	4.73e-05	0.00105	CbGpPWpGaD
Propofol—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	4.7e-05	0.00105	CbGpPWpGaD
Propofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—colon cancer	4.68e-05	0.00104	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—BRAF—colon cancer	4.62e-05	0.00103	CbGpPWpGaD
Propofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	4.61e-05	0.00103	CbGpPWpGaD
Propofol—GABRB2—Transmembrane transport of small molecules—ABCB1—colon cancer	4.58e-05	0.00102	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—colon cancer	4.58e-05	0.00102	CbGpPWpGaD
Propofol—ALB—Platelet degranulation—VEGFA—colon cancer	4.57e-05	0.00102	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	4.57e-05	0.00102	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—colon cancer	4.48e-05	0.000997	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	4.48e-05	0.000997	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—CHST5—colon cancer	4.42e-05	0.000983	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ODC1—colon cancer	4.42e-05	0.000983	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—EP300—colon cancer	4.4e-05	0.000979	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—EP300—colon cancer	4.4e-05	0.000979	CbGpPWpGaD
Propofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	4.35e-05	0.000969	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ODC1—colon cancer	4.33e-05	0.000963	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—CHST5—colon cancer	4.33e-05	0.000963	CbGpPWpGaD
Propofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	4.32e-05	0.000962	CbGpPWpGaD
Propofol—GABRA2—Transmembrane transport of small molecules—ABCB1—colon cancer	4.3e-05	0.000956	CbGpPWpGaD
Propofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	4.29e-05	0.000956	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CA7—colon cancer	4.29e-05	0.000955	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—SRC—colon cancer	4.28e-05	0.000952	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—SRC—colon cancer	4.28e-05	0.000952	CbGpPWpGaD
Propofol—GABRB3—Transmembrane transport of small molecules—ABCB1—colon cancer	4.27e-05	0.00095	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—ABCB1—colon cancer	4.23e-05	0.000942	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—colon cancer	4.23e-05	0.000941	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	4.23e-05	0.000941	CbGpPWpGaD
Propofol—SCN4A—Axon guidance—HRAS—colon cancer	4.22e-05	0.000939	CbGpPWpGaD
Propofol—SCN2A—Axon guidance—HRAS—colon cancer	4.22e-05	0.000939	CbGpPWpGaD
Propofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	4.22e-05	0.000939	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—HRAS—colon cancer	4.2e-05	0.000935	CbGpPWpGaD
Propofol—ALB—Platelet degranulation—TGFB1—colon cancer	4.19e-05	0.000933	CbGpPWpGaD
Propofol—GABRG2—Transmembrane transport of small molecules—ABCB1—colon cancer	4.19e-05	0.000933	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—VEGFA—colon cancer	4.16e-05	0.000927	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—VEGFA—colon cancer	4.16e-05	0.000927	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—TYMS—colon cancer	4.16e-05	0.000925	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—NRAS—colon cancer	4.11e-05	0.000916	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—NRAS—colon cancer	4.11e-05	0.000916	CbGpPWpGaD
Propofol—CYP1A1—PPARA activates gene expression—EP300—colon cancer	4.1e-05	0.000913	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—CHST5—colon cancer	4.08e-05	0.000908	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ODC1—colon cancer	4.08e-05	0.000908	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PPARG—colon cancer	4.04e-05	0.000898	CbGpPWpGaD
Propofol—ALB—Folate Metabolism—TP53—colon cancer	4.03e-05	0.000896	CbGpPWpGaD
Propofol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	4.01e-05	0.000894	CbGpPWpGaD
Propofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	3.99e-05	0.000889	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—TGFB1—colon cancer	3.82e-05	0.000851	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—TGFB1—colon cancer	3.82e-05	0.000851	CbGpPWpGaD
Propofol—CYP2A6—NRF2 pathway—TGFB1—colon cancer	3.82e-05	0.000849	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—EGFR—colon cancer	3.75e-05	0.000834	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—EGFR—colon cancer	3.75e-05	0.000834	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—CHST5—colon cancer	3.74e-05	0.000832	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ODC1—colon cancer	3.74e-05	0.000832	CbGpPWpGaD
Propofol—ALB—Metabolism—ODC1—colon cancer	3.72e-05	0.000827	CbGpPWpGaD
Propofol—ALB—Metabolism—CHST5—colon cancer	3.72e-05	0.000827	CbGpPWpGaD
Propofol—GABRB3—BDNF signaling pathway—AKT1—colon cancer	3.71e-05	0.000825	CbGpPWpGaD
Propofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—colon cancer	3.69e-05	0.00082	CbGpPWpGaD
Propofol—GABRA1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.66e-05	0.000816	CbGpPWpGaD
Propofol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—colon cancer	3.6e-05	0.0008	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—KRAS—colon cancer	3.54e-05	0.000788	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—KRAS—colon cancer	3.54e-05	0.000788	CbGpPWpGaD
Propofol—GABRB2—Transmission across Chemical Synapses—HRAS—colon cancer	3.47e-05	0.000771	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ODC1—colon cancer	3.34e-05	0.000743	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—CHST5—colon cancer	3.34e-05	0.000743	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CA7—colon cancer	3.31e-05	0.000737	CbGpPWpGaD
Propofol—GABRA2—Transmission across Chemical Synapses—HRAS—colon cancer	3.25e-05	0.000723	CbGpPWpGaD
Propofol—GABRB3—Transmission across Chemical Synapses—HRAS—colon cancer	3.23e-05	0.000719	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PTGS2—colon cancer	3.17e-05	0.000707	CbGpPWpGaD
Propofol—GABRG2—Transmission across Chemical Synapses—HRAS—colon cancer	3.17e-05	0.000706	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ODC1—colon cancer	3.07e-05	0.000683	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—CHST5—colon cancer	3.07e-05	0.000683	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—CHST5—colon cancer	3.04e-05	0.000677	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ODC1—colon cancer	3.04e-05	0.000677	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—HRAS—colon cancer	3.01e-05	0.00067	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—HRAS—colon cancer	3.01e-05	0.00067	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PPARG—colon cancer	2.94e-05	0.000655	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.93e-05	0.000652	CbGpPWpGaD
Propofol—GABRA1—Transmission across Chemical Synapses—HRAS—colon cancer	2.77e-05	0.000617	CbGpPWpGaD
Propofol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	2.77e-05	0.000616	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.73e-05	0.000609	CbGpPWpGaD
Propofol—SCN4A—Developmental Biology—AKT1—colon cancer	2.66e-05	0.000591	CbGpPWpGaD
Propofol—SCN2A—Developmental Biology—AKT1—colon cancer	2.66e-05	0.000591	CbGpPWpGaD
Propofol—GABRB2—Neuronal System—HRAS—colon cancer	2.66e-05	0.000591	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—EP300—colon cancer	2.64e-05	0.000588	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—CHST5—colon cancer	2.6e-05	0.000579	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ODC1—colon cancer	2.6e-05	0.000579	CbGpPWpGaD
Propofol—GABRA2—Neuronal System—HRAS—colon cancer	2.49e-05	0.000554	CbGpPWpGaD
Propofol—GABRB3—Neuronal System—HRAS—colon cancer	2.47e-05	0.000551	CbGpPWpGaD
Propofol—GABRG2—Neuronal System—HRAS—colon cancer	2.43e-05	0.000541	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—ABCB1—colon cancer	2.37e-05	0.000528	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—TYMS—colon cancer	2.33e-05	0.000519	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PTGS2—colon cancer	2.32e-05	0.000515	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.31e-05	0.000513	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.15e-05	0.000479	CbGpPWpGaD
Propofol—GABRA1—Neuronal System—HRAS—colon cancer	2.12e-05	0.000473	CbGpPWpGaD
Propofol—ALB—Transmembrane transport of small molecules—ABCB1—colon cancer	2.1e-05	0.000467	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—SRC—colon cancer	2.08e-05	0.000463	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—VEGFA—colon cancer	2.03e-05	0.000451	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ODC1—colon cancer	2.01e-05	0.000447	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—CHST5—colon cancer	2.01e-05	0.000447	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—PIK3CA—colon cancer	1.95e-05	0.000435	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—EP300—colon cancer	1.93e-05	0.000429	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.92e-05	0.000427	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—ABCB1—colon cancer	1.88e-05	0.000418	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—ABCB1—colon cancer	1.88e-05	0.000418	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.86e-05	0.000414	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—TYMS—colon cancer	1.84e-05	0.00041	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—TYMS—colon cancer	1.84e-05	0.00041	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.79e-05	0.000398	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—ABCB1—colon cancer	1.75e-05	0.00039	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—TYMS—colon cancer	1.72e-05	0.000383	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.68e-05	0.000375	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PPARG—colon cancer	1.65e-05	0.000368	CbGpPWpGaD
Propofol—UGT1A8—Metabolism—AKT1—colon cancer	1.6e-05	0.000355	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	1.58e-05	0.000352	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.54e-05	0.000344	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.53e-05	0.000342	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—ABCB1—colon cancer	1.45e-05	0.000322	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—PIK3CA—colon cancer	1.42e-05	0.000317	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—TYMS—colon cancer	1.42e-05	0.000316	CbGpPWpGaD
Propofol—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.42e-05	0.000316	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.38e-05	0.000307	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.32e-05	0.000295	CbGpPWpGaD
Propofol—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.32e-05	0.000295	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PPARG—colon cancer	1.31e-05	0.000291	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PPARG—colon cancer	1.31e-05	0.000291	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PTGS2—colon cancer	1.3e-05	0.000289	CbGpPWpGaD
Propofol—ALB—Platelet activation, signaling and aggregation—AKT1—colon cancer	1.29e-05	0.000288	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.26e-05	0.00028	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PPARG—colon cancer	1.22e-05	0.000271	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.21e-05	0.00027	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.21e-05	0.000269	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—ABCB1—colon cancer	1.17e-05	0.00026	CbGpPWpGaD
Propofol—UGT1A6—Metabolism—AKT1—colon cancer	1.16e-05	0.000259	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—TYMS—colon cancer	1.15e-05	0.000255	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—ABCB1—colon cancer	1.14e-05	0.000254	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—TYMS—colon cancer	1.12e-05	0.00025	CbGpPWpGaD
Propofol—ALB—Hemostasis—EP300—colon cancer	1.1e-05	0.000245	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.1e-05	0.000245	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.08e-05	0.000241	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—EP300—colon cancer	1.08e-05	0.00024	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—ABCB1—colon cancer	1.08e-05	0.00024	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.07e-05	0.000239	CbGpPWpGaD
Propofol—ALB—Hemostasis—SRC—colon cancer	1.07e-05	0.000239	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—TYMS—colon cancer	1.06e-05	0.000236	CbGpPWpGaD
Propofol—ALB—Hemostasis—VEGFA—colon cancer	1.04e-05	0.000233	CbGpPWpGaD
Propofol—ALB—Hemostasis—NRAS—colon cancer	1.03e-05	0.00023	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PTGS2—colon cancer	1.03e-05	0.000229	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PTGS2—colon cancer	1.03e-05	0.000229	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.01e-05	0.000225	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PPARG—colon cancer	1.01e-05	0.000224	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—EP300—colon cancer	1e-05	0.000223	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.88e-06	0.00022	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—ABCB1—colon cancer	9.88e-06	0.00022	CbGpPWpGaD
Propofol—ALB—Metabolism—ABCB1—colon cancer	9.82e-06	0.000219	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—TYMS—colon cancer	9.7e-06	0.000216	CbGpPWpGaD
Propofol—ALB—Metabolism—TYMS—colon cancer	9.65e-06	0.000215	CbGpPWpGaD
Propofol—ALB—Hemostasis—TGFB1—colon cancer	9.59e-06	0.000213	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PTGS2—colon cancer	9.58e-06	0.000213	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.01e-06	0.000201	CbGpPWpGaD
Propofol—ALB—Hemostasis—KRAS—colon cancer	8.88e-06	0.000198	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—ABCB1—colon cancer	8.82e-06	0.000196	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—TYMS—colon cancer	8.66e-06	0.000193	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—EP300—colon cancer	8.54e-06	0.00019	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—EP300—colon cancer	8.54e-06	0.00019	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.44e-06	0.000188	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.22e-06	0.000183	CbGpPWpGaD
Propofol—ALB—Hemostasis—PIK3CA—colon cancer	8.16e-06	0.000182	CbGpPWpGaD
Propofol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	8.15e-06	0.000181	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PPARG—colon cancer	8.12e-06	0.000181	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—ABCB1—colon cancer	8.11e-06	0.000181	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—ABCB1—colon cancer	8.04e-06	0.000179	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—PIK3CA—colon cancer	7.99e-06	0.000178	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—TYMS—colon cancer	7.97e-06	0.000177	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—EP300—colon cancer	7.97e-06	0.000177	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PPARG—colon cancer	7.95e-06	0.000177	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PTGS2—colon cancer	7.92e-06	0.000176	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—TYMS—colon cancer	7.9e-06	0.000176	CbGpPWpGaD
Propofol—ALB—Hemostasis—TP53—colon cancer	7.89e-06	0.000176	CbGpPWpGaD
Propofol—ALB—Hemostasis—HRAS—colon cancer	7.55e-06	0.000168	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PPARG—colon cancer	7.5e-06	0.000167	CbGpPWpGaD
Propofol—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.47e-06	0.000166	CbGpPWpGaD
Propofol—ALB—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.43e-06	0.000165	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.02e-06	0.000156	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PPARG—colon cancer	6.87e-06	0.000153	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—ABCB1—colon cancer	6.87e-06	0.000153	CbGpPWpGaD
Propofol—ALB—Metabolism—PPARG—colon cancer	6.83e-06	0.000152	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—TYMS—colon cancer	6.75e-06	0.00015	CbGpPWpGaD
Propofol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.67e-06	0.000148	CbGpPWpGaD
Propofol—ALB—Hemostasis—AKT1—colon cancer	6.67e-06	0.000148	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—EP300—colon cancer	6.58e-06	0.000147	CbGpPWpGaD
Propofol—CYP2C18—Metabolism—AKT1—colon cancer	6.53e-06	0.000145	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PTGS2—colon cancer	6.39e-06	0.000142	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—PIK3CA—colon cancer	6.32e-06	0.000141	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—PIK3CA—colon cancer	6.32e-06	0.000141	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PTGS2—colon cancer	6.26e-06	0.000139	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PPARG—colon cancer	6.14e-06	0.000137	CbGpPWpGaD
Propofol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.08e-06	0.000135	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PTGS2—colon cancer	5.9e-06	0.000131	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—PIK3CA—colon cancer	5.89e-06	0.000131	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PPARG—colon cancer	5.64e-06	0.000126	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PPARG—colon cancer	5.59e-06	0.000125	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PTGS2—colon cancer	5.41e-06	0.00012	CbGpPWpGaD
Propofol—ALB—Metabolism—PTGS2—colon cancer	5.38e-06	0.00012	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—EP300—colon cancer	5.31e-06	0.000118	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—ABCB1—colon cancer	5.3e-06	0.000118	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—TYMS—colon cancer	5.21e-06	0.000116	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—EP300—colon cancer	5.2e-06	0.000116	CbGpPWpGaD
Propofol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.2e-06	0.000116	CbGpPWpGaD
Propofol—UGT1A1—Metabolism—AKT1—colon cancer	5.16e-06	0.000115	CbGpPWpGaD
Propofol—UGT1A9—Metabolism—AKT1—colon cancer	5.16e-06	0.000115	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—EP300—colon cancer	4.91e-06	0.000109	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—PIK3CA—colon cancer	4.87e-06	0.000108	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PTGS2—colon cancer	4.83e-06	0.000107	CbGpPWpGaD
Propofol—CYP1B1—Metabolism—AKT1—colon cancer	4.81e-06	0.000107	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PPARG—colon cancer	4.78e-06	0.000106	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—EP300—colon cancer	4.5e-06	0.0001	CbGpPWpGaD
Propofol—ALB—Metabolism—EP300—colon cancer	4.47e-06	9.95e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PTGS2—colon cancer	4.44e-06	9.88e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PTGS2—colon cancer	4.4e-06	9.8e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—EP300—colon cancer	4.01e-06	8.94e-05	CbGpPWpGaD
Propofol—CYP2A6—Metabolism—AKT1—colon cancer	3.98e-06	8.86e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—PIK3CA—colon cancer	3.93e-06	8.75e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—PIK3CA—colon cancer	3.85e-06	8.57e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PTGS2—colon cancer	3.76e-06	8.37e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—EP300—colon cancer	3.69e-06	8.22e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PPARG—colon cancer	3.69e-06	8.21e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—EP300—colon cancer	3.66e-06	8.15e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—PIK3CA—colon cancer	3.63e-06	8.08e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—PIK3CA—colon cancer	3.33e-06	7.41e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—PIK3CA—colon cancer	3.31e-06	7.36e-05	CbGpPWpGaD
Propofol—CYP2B6—Metabolism—AKT1—colon cancer	3.21e-06	7.15e-05	CbGpPWpGaD
Propofol—CYP2E1—Metabolism—AKT1—colon cancer	3.14e-06	7e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—EP300—colon cancer	3.13e-06	6.96e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—PIK3CA—colon cancer	2.97e-06	6.61e-05	CbGpPWpGaD
Propofol—CYP1A1—Metabolism—AKT1—colon cancer	2.96e-06	6.6e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PTGS2—colon cancer	2.9e-06	6.46e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—PIK3CA—colon cancer	2.73e-06	6.08e-05	CbGpPWpGaD
Propofol—CYP2C8—Metabolism—AKT1—colon cancer	2.72e-06	6.05e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—PIK3CA—colon cancer	2.71e-06	6.03e-05	CbGpPWpGaD
Propofol—ALB—Metabolism—AKT1—colon cancer	2.7e-06	6.01e-05	CbGpPWpGaD
Propofol—CYP2C19—Metabolism—AKT1—colon cancer	2.43e-06	5.4e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—EP300—colon cancer	2.41e-06	5.37e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—PIK3CA—colon cancer	2.31e-06	5.15e-05	CbGpPWpGaD
Propofol—CYP2D6—Metabolism—AKT1—colon cancer	2.23e-06	4.97e-05	CbGpPWpGaD
Propofol—CYP2C9—Metabolism—AKT1—colon cancer	2.21e-06	4.92e-05	CbGpPWpGaD
Propofol—CYP1A2—Metabolism—AKT1—colon cancer	1.89e-06	4.21e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—PIK3CA—colon cancer	1.79e-06	3.97e-05	CbGpPWpGaD
Propofol—CYP3A4—Metabolism—AKT1—colon cancer	1.46e-06	3.25e-05	CbGpPWpGaD
